FLIXOTIDE

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug FLIXOTIDE contains one active pharmaceutical ingredient (API):

1	Fluticasone UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE
	Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.
	Read more about Fluticasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLIXOTIDE EVOHALER Pressurised inhalation, suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC17	Fluticasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC17
R01AD08	Fluticasone	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD08
R03BA05	Fluticasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8147T, 8148W, 8149X, 8345F, 8346G, 8516F
BR	Câmara de Regulação do Mercado de Medicamentos	510603101177319, 510603102173317, 510603103171318, 510603105121415, 510615040053905, 510615040054005, 510617030056603, 510617030056703
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.704-05-07, 27.705-05-07, 29262-06-10
EE	Ravimiamet	1007840, 1007862, 1007884, 1130690
ES	Centro de información online de medicamentos de la AEMPS	60477, 60479, 60480, 60482
FI	Lääkealan turvallisuus- ja kehittämiskeskus	002558, 082685, 082719, 135434, 521047, 521062, 555870
FR	Base de données publique des médicaments	61856322, 62933355, 64115257, 65156075, 66545581, 68652265
GB	Medicines & Healthcare Products Regulatory Agency	138766, 138768, 138770, 138776, 138779, 142338, 142340, 142342, 142344, 142346, 142348, 142350, 142352, 161797, 161799, 161801, 161803, 161805, 161807, 199651, 28293, 28309, 28314, 31839, 31844, 31850, 31854, 33896, 33994, 374463, 374465, 374467
HK	Department of Health Drug Office	38094, 38095, 38096, 45661
HR	Agencija za lijekove i medicinske proizvode	HR-H-145522875, HR-H-226045614, HR-H-977557368
IE	Health Products Regulatory Authority	24809, 24867, 25640, 25671, 25682, 25694, 26001, 26012, 26024, 26036, 26048, 26135, 26142, 26153
IL	מִשְׂרַד הַבְּרִיאוּת	3537, 3538, 3539, 3540, 4030, 4031, 4032, 4033, 4784
IT	Agenzia del Farmaco	028667095, 028667107
LT	Valstybinė vaistų kontrolės tarnyba	1000776, 1000777, 1000778, 1000779, 1000781, 1000782, 1003495, 1006996, 1092582
MT	Medicines Authority	MA192/00401, MA192/00402, MA192/00403, MA192/00404, MA192/00405, PI908/21601A, PI908/21602A, PI908/21603A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	172M95, 390M99
NG	Registered Drug Product Database	B4-8511, B4-9147
Switch country to Nigeria in order to find specific presentations of FLIXOTIDE
NL	Z-Index G-Standaard	13813455, 13813471, 13813544, 14039311, 14039338, 14039346, 14236680, 14236699
NL	Z-Index G-Standaard, PRK	106151, 39055, 39063, 39071, 45624, 45632, 51462, 66664
NZ	Medicines and Medical Devices Safety Authority	5256, 5260, 5267, 5268, 5269, 5270, 8606
PL	Rejestru Produktów Leczniczych	100093955, 100093961, 100099225, 100099231, 100099248, 100109751, 100194751, 100228361, 100233439
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65201001, W65201002, W65204003, W65204004, W65205003, W65205004, W65206001, W65206002, W65207001, W65207002, W65208001, W65208002, W65209001
SG	Health Sciences Authority	11112P, 11347P, 11348P, 11358P
TN	Direction de la Pharmacie et du Médicament	2113071, 5163071
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522521500, 8699522521517, 8699522523528, 8699522523535, 8699522523603, 8699522523610, 8699522553556, 8699522553563, 8699522553570, 8699522553587, 8699522553594
ZA	Health Products Regulatory Authority	30/21.5.1/0068, 30/21.5.1/0069, 30/21.5.1/0070, 30/21.5.1/0071, 32/21.5.1/0082, 32/21.5.1/0083, 35/21.5.1/0377